BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv Anat Pathol 2017;24:354-61. [PMID: 28787279 DOI: 10.1097/PAP.0000000000000164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Alkanat NE, Uner A, Usubutun A. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Int J Surg Pathol 2022;:10668969221098087. [PMID: 35506912 DOI: 10.1177/10668969221098087] [Reference Citation Analysis]
2 Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
4 Almoiliqy M, Al-Danakh A, Safi M, Alradhi M, Al-Azab M, Adlat S, Zhou W, Mohammed ASA, Al-Maamari A. Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States. Oxid Med Cell Longev 2021;2021:9999529. [PMID: 34007412 DOI: 10.1155/2021/9999529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res 2020;26:3881-8. [PMID: 32299819 DOI: 10.1158/1078-0432.CCR-19-3959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
7 Shao Y, Liu Q, Shi H, Lu B. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases. Diagn Pathol 2020;15:35. [PMID: 32290854 DOI: 10.1186/s13000-020-00956-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
9 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]